Short-term dietary copper deficiency does not inhibit angiogenesis in tumours implanted in striated muscle. by Schuschke, D. A. et al.
Br. J. Cancer (1992), 66, 1059-1064 1992
Short-term dietary copper deficiency does not inhibit angiogenesis in
tumours implanted in striated muscle
D.A. Schuschkel, M.W.R. Reed2, J.T. Saari3, M.D. Olson4, D.M. Ackermann5 & F.N. Miller'
Department ofPhysiology andBiophysics, 'The Centerfor Applied Microcirculatory Research, and 5Department ofPathology, University ofLouisville, Louisville, Kentucky 40292; 2Department ofSurgery, University ofSheffield, Sheffield, UnitedKingdom SJO 2JF; 3United States Department ofAgriculture, Agriculture Research Service, Human Nutrition Research Center and 4Department ofAnatomy, University ofNorth Dakota, Grand Forks, North Dakota 58202, USA.
Summary The effect of dietary copper deficiency on tumour growth, neovascularisation and microvascular
integrity was studied in the rat cremaster muscle. Male, weanling Sprague-Dawley rats were fed purified diets
which were copper deficient (<0.5 ig g-' of diet) or copper adequate (5 tg g-' of diet). Seven days after initiation of diets, a chondrosarcoma was implanted in the cremaster muscle of each rat. Five, 10 or 20 days
after tumour implantation, rats were anesthetised and their cremasters prepared for observation by intravital
microscopy. Intraarterial injection of fluorescein isothiocyanate-conjugated albumin and subsequent observa-
tion of fluorescence in the perivascular space indicated no difference in microvascular albumin leakage between
the tumour vasculature of copper deficient and copper adequate rats. Neither tumour growth (assessed by wet weight), vascular density (assessed by light microscopy), nor any ultrastructural characteristics of the tumour
or its vasculature (assessed by electron microscopy) were affected by copper deficiency. In view of findings by others which indicate changes in tumour characteristics with copper deficiency, we conclude that the copper dependency of tumour growth and vascularisation is a function of the type of tumour, the host tissue, or the
conditions of copper depletion.
Angiogenesis occurs physiologically in wound healing and in
the endometrium. It also occurs in a variety of pathological
disorders including diabetes, rheumatoid arthritis, and psor-
iasis. In addition, there is now considerable experimental
evidence that tumour growth and metastasis are also depen-
dent on angiogenesis (Folkman, 1990).
A number of factors may modulate the development of
new blood vessels in response to angiogenic stimuli (Folkman
& Klagsbrun, 1987). In particular, copper deficiency was
shown to inhibit angiogenesis in the rabbit cornea induced by
prostaglandin E and BALB/C fibroblasts (Ziche et al., 1982).
More recently, Brem and co-workers found that a copper
deficient diet combined with the copper chelating agent
penicillamine inhibited growth of VX2 carcinoma in the
brain. Tumours in the rabbit brain remained in an avascular
state and failed to develop beyond small nodules. Similar
results were observed in the growth and development of rat
9L gliosarcoma (Brem et al., 1990a and b).
The only report of the effect of copper deficiency in
tumours outside the brain was recently presented (Brem et
al., 1990a). In contrast to the brain, where copper deficiency
and penicillamine inhibited angiogenesis and tumour growth,
there was no inhibition when the same tumour was implanted
in the thigh muscle of the same animals. Furthermore, there
is limited reported data on the effects of dietary copper
deficiency alone (without penicillamine) on tumour angio-
genesis (Brem et al., 1990a).
In the current study, the effect of diet-induced copper
deficiency alone on neovascularisation, microvessel integrity,
and growth of an experimental sarcoma was studied in
striated muscle. The tumour was implanted into the rat
cremaster muscle and the microcirculation was observed in
vivo by television microscopy and structurally by light and
electron microscopy.
Materials and methods
Thirty-six male, weanling Sprague-Dawley rats were housed
individually in stainless steel cages in a temperature and
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humidity controlled room with a 12 h light-dark cycle. They
were given distilled water to drink and were fed ad libitum a
purified diet which was either adequate for dietary copper
(5 figg' supplemental copper; CuA diet) or contained no
supplemental copper (OLgg'; CuD diet). The CuA diet
corresponded closely to the AIN-76 diet recommended for
rats with the copper content equal to that recommended by
the National Research Council (AIN Report, 1977). Details
of the diet are given in Table I. The animals were maintained
on their respective diets for 7 days prior to tumour cell
implantation and during the subsequent tumour growth
periods. Recent work has demonstrated that several copper
status indices, including plasma and liver copper concentra-
tions and liver Cu, Zn superoxide dismutase activity are
significantly reduce by 1 week on the CuD diet (Johnson &
Saari, 1991).
A transplantable rat chondrosarcoma was implanted into
the cremaster muscle by the following procedure (Reed et al.,
1989). A tumour cell suspension was prepared in Hank's
balanced salt solution (Gibco Laboratories) by fragmentation
of approximately 1 cm2 of tumour and passage through
graded needles. A fresh cell suspension was prepared daily
and an equal number of CuA and CuD rats were implanted
from each suspension. Animals were anesthetised with pen-
tobarbital (50 mgkg-1). The cremaster was exposed at lapar-
otomy by retracting the testis into the abdominal cavity and
0.05 ml of cell suspension (1.5 x I05 cells ml-) was injected
into the cremaster through a 25 gauge needle at an optimal
position for future microcirculatory study. The tumour was
maintained in a separate group of animals by weekly passage
using subcutaneous injection of cell suspension in normal
chow fed rats.
Five, 10 or 20 days after tumour implantation, the rats
were anesthetised with pentobarbital (50 mg kg-') and a
tracheal cannula was inserted to maintain a patent airway.
The carotid artery was cannulated and the blood pressure and heart rate were monitored with a Micro Med Blood
Pressure Analyzer. The skin of the right scrotum was opened
and the cremaster incised longitudinally and spread with
sutures over a cover slip in the bottom of a specially designed plexiglass bath containing modified Krebs solution. Nerves
and blood vessels to the cremaster from the animal remained
intact. The Krebs solution was replaced every 15 nmn and
was maintained at pH 7.4 ± 0.05 by bubbling nitrogen and
carbon dioxide into the bath. A negative feedback system which connected a bath thermocouple to an indwelling heater
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Ferric citrate * n-hydrate (16% Fe) 0.22
CuA CuD
Corn starch 9.76 9.78
Cupric sulfate 5 S hydrate 0.02 0
The basal diet was a casein (200gkg-')-, sucrose (390gkg-')-,
and cornstarch (290 g kg-')-based diet containing all known essential
minerals and vitamins except iron and copper (Teklad Test Diets,
Madison, WI.;-cat. no TD 84469. Safflower oil was from Hollywood
foods, Los Angeles, CA. Ferric citrate * n-hydrate and cupric sulfate
* 5 hydrate were from J.T. Baker chemical, Phillipsburg, NJ. The
cornstarch was from Best Food, Englewood Cliffs, NJ.
coil was used to maintain the bath at 36 ± 0.5°C. Animals
were placed on a heating pad to maintain rectal temperature
at 35 to 37°C.
The animal and tissue bath were positioned on a modified
stage of a Leitz fluorescent microscope so that the cremaster,
which is approximately 200-250gim thick, could be observed
by transmitted light or fluorescent microscopy. A closed
circuit television system was used to monitor the experiments
which were recorded on videotape for later analysis. The
magnification of the system was determined by using a stage
micrometer to allow for vessel diameter measurements. The
emission intensity of fluorescein isothiocyanate tagged to
bovine serum albumin (FITC-BSA) was used to assess mac-
romolecular leakage and as an index of vascular integrity
(Schuschke et al., 1989).
Following the surgical preparation and preceding each
experiment, there was a 1 h equilibration period. After the
equilibration period, FITC-BSA (0.2 ml 100g-1) was injected
intra-arterially in the 5 and 10-day post-implantation groups.
The 20-day animals were omitted from the macromolecular
leakage studies because of difficulty in preserving an intact
tumour during dissection from the surrounding connective
tissue when the tumour had enlarged. To study spontaneous
macromolecular leakage from the tumour microcirculation, a
region adjacent to a small tumour venule (20-301im) was
studied immediately after FITC-BSA administration and
again 20min later. At each time, fluorescent images were
recorded during brief epi-illumination with blue light
(450-490 nm) from a mercury arc lamp.
For analysis of macromolecular leakage, the fluorescent
image was digitised by a PC VISION PC PLUS image
analysis system. Using this system the image was digitised to
pixels of varying gray level (gray levels range from zero to
255 with zero being black and 255 being white). The data
were then converted to a histogram showing the number of
pixels of each gray level within the image. From the histo-
gram data, an average gray level was calculated for each
image. This gray level was expressed as fluorescent intensity
units and provides an index ofmacromolecular leakage in the
area of interest (Schuschke et al., 1989).
At the end of the in vivo experimentation, the size and wet
weight of the tumour were recorded and specimens were
taken for light and electron microscopy. Light microscopy
specimens were fixed in buffered formaldehyde, dehydrated
through graded alcohols and mounted in paraffin blocks. The
paraffin blocks were then step sectioned at 5ltm intervals,
placed on glass slides, and stained with routine hematoxylin
and eosin. The angiogenic response was assessed semi-
quantitatively by determining vascular density per high
power field in the area of maximum vascular density (Brem
et al., 1972).
For electron microscopy, specimens (approximately 1 mm3)
were fixed in Karnovsky's fixative (paraformaldehyde/glutar-
aldehyde) in 0.2 N cacodylate buffer for 2h, rinsed in buffer,
post-fixed in osmium tetroxide in 0.144 N cacodylate buffer
for 1 h followed by a buffer rinse. Specimens were subse-
quently dehydrated in an ascending graded series of ethanol
followed by propylene oxide. Tissues were then immersed in
propylene oxide/Epon 812-Araldite, first in a 1:1 mixture for
1 h followed by a 1:3 ratio for 4 h or overnight under
vacuum. All tissues were then placed in 100% Epon 812-
Araldite for 1 h, followed by embedding in the same epoxy
resin. The resin tissue blocks were polymerised for 36 h,
trimmed, and thick and thin sectioned on an ultramicrotome.
Thick sections were mounted on glass slides, stained with
toluidine blue, and viewed in a Nikon Microphot FX light
microscope. Thin sections (70-80 nm) were collected on cop-
per grids, stained with alcoholic uranyl acetate and aqueous
lead citrate, and examined and photographed in a JEOL
1OOS transmission electron microscope.
The median lobe of the liver was removed and frozen for
analysis of copper content. Specimens were subsequently
freeze dried and digested in nitric acid and hydrogen perox-
ide (Nielsen et al., 1982). Copper analysis was performed
using a Jarrell-Ash Model 1140 inductively coupled plasma
emission spectrometer.
Statistical analysis was by analysis of variance (ANOVA)
followed by Tukey's studentised range test if an interaction
between variables was revealed. Differences were considered
significant at P<0.05.
Results
Diet analysis indicated that the CuD diet contained 0.38-
0.55 ;g Cu g' diet and that the CuA diet contained
5.23-5.60.g Cug-1 diet. The CuD diet caused a
significantly lower liver copper content compared to the CuA
contol group at all times tested (Figure 1). However, an
extended time on the copper deficient diet did not
significantly alter liver copper content from that seen at 5
days. Dietary copper deficiency did not cause changes in
body weight, heart rate, or blood pressure (Table II).
In vivo experimentation did not demonstrate a difference in
spontaneous macromolecular leakage from the tumour vas-
culature between the groups. Interstitial gray level within
1 min after FITC-BSA injection was not different between
CuA and CuD groups (Figure 2) in either the 5 or 10-day
groups. There was also no difference in gray level between
groups 20 min after FITC-BSA injection. Analysis of the
correlation between copper content and macromolecular
leakage by linear regression gave a correlation coefficient of
0.54 which-was not statistically significant.
Dietary copper deficiency did not to alter the rate of
growth of the tumour at any of the times tested (Figure 3).
There was also no difference in the vascular density during
the development of the tumour (Figure 4).
Electron microscopy failed to demonstrate ultrastructural
differences in tumour cells or endothelial cells between the
CuA and CuD groups. The tumour cells within the lacunae
had the typical morphology and associated circumferential
extracellular matrix (ECM) which characterises chondrocytes
and cartilaginous matrices. Associated with the ECM were
fine non-striated Type II collagenous fibrils and scattered
glycosaminoglycan matrix granules which typify the ECM
associated with cartilage. The interface between endothelial
cells was normal with tightjunctions and interdigitating plas-
malemmas. There was no demonstrable disruption of junc-
tional complexes or significant thickening of the underlying
basement membrane identified in the endothelial cells of
tumour blood vessels.
Discussion
Most studies involving the role of copper in angiogenesis
have used the rabbit cornea as a model for experimentation.
Results from experimentation with the cornea demonstrate
that tissue copper levels increase prior to angiogenesis (Ziche
et al., 1982). Copper was previously shown to complex with
fibroblast growth factor (FGF) (Shing, 1988), heparin, and
ceruloplasmin (Raju et al., 1984) thus making these agents
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Figure 1 Hepatic copper concentration of animals fed either a diet adequate for copper (5 ppm) or deficient for copper (0 ppm).
The diets were started 7 days before tumour implantation and the concentrations were quantitated 5, 10, or 20 days after the
implantation. All values are X ± s.e. Two-way ANOVA indicated an interaction between diet and time (P< 0.02) with Tukey's
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Figure 2 Perivascular interstitial fluorescent intensity as an index of tumour venule macromolecular leakage. Measurements were
made immediately after injection of FITC-BSA injection and again 20 min later. All values are X ± s.e. Three-way ANOVe showed
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Figure 3 Tumour weight as an index of growth 5, 10, and 20 days after tumour implantation. All values are X ± s.e. Two-way
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Figure 4 Tumour vascular density as an index of angiogenesis 5, 10, and 20 days after tumour implantation. All values are
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Table II Characteristics of copper-adequate (CuA) and copper-deficient (CUD) animals
S day 10 day 20 day
Variable CuA CuD CuA CuD CuA CuD
n size 6 5 5 5 7 8
Body Weight 165±4 162±7 210±7 215± 14 289 13 262 10
(grams)
Heart Rate 459 ± 13 445 ± 20 467 ± 25 466 ± 27 443 21 429 12
(BPM)
Mean Blood 124±3 124± 5 130± 5 125± 5 124 5 121 3
Pressure (mmHg)
All values are mean ± s.e.
and augmentation of endothelial locomotion in vivo (McAus-
lan & Reilly, 1980) are also copper-dependent.
Recently, evidence for inhibition of angiogenesis and tu-
mour growth by copper depletion was presented. These
studies included several types of human brain tumours
implanted in rabbit cornea (Alpern-Elran & Brem, 1985), 9L
gliosarcoma in rat brain (Brem et al., 1990a and b), and VX2
carcinoma in rabbit brain (Brem et al., 1990a). In these
studies, the animals were made copper deficient by dietary
restriction of copper intake and the addition of the copper
chelator penicillamine.
In contrast to these previous studies, we now report that a
significant, diet-induced copper deficiency (Figure 1) does not
alter tumour growth or angiogenesis in striated muscle.
Tumour weight (Figure 3), microvascular density (Figure 4),
and morphology were not influenced by dietary copper.
There were also no differences in body weight, blood pres-
sure, or heart rate in the CuD animals compared to controls
(Table II).
In addition to tumour and blood vessel growth parameters
there was no physiologic (Figure 2) evidence for a difference
in tumour vasculature between CuA and CuD animals. Vas-
cular integrity as assessed by macromolecular leakage was
not different between the tumours of the CuA and CuD
animals. While some tumours show an enhanced leakage
with time, the chondrosarcoma was previously shown to have
a relatively intact and 'non-leaky' vasculature (Heuser &
Miller, 1986). In this study, copper deficiency did not alter
the leakage characteristics of this tumour model (Figure 2).
There are several possible reasons for the differences seen
in the present data compared to prior work with copper
deficiency. The current study was done in animals made
copper deficient by restriction of dietary intake of copper but
without the addition of penicillamine. Since penicillamine has
been shown to inhibit angiogenesis (Matsubara et al., 1989)
independent of its role as a copper chelator, it may have a
role in the restriction of angiogenesis and tumour growth
that has been attributed to copper deficiency.
Susceptibility to copper-deficiency may be tumour-specific.
Tumour angiogenesis was previously shown to be dependent
on the type of tumour implanted (Alpern-Elran & Brem,
1985). Their study demonstrated the inhibition of angio-
genesis in some but not all human brain tumours implanted
in the rabbit cornea of copper-depleted, penicillamine-treated
rabbits.
Tumour angiogenesis also was shown to be host tissue-
dependent. Brem et al. (1990a) reported that copper deple-
tion and penicillamine treatment failed to inhibit tumour
growth and the vascularisation of the VX2 carcinoma in the
rabbit thigh muscle while inhibition of tumour growth was
present in the brain. This finding combined with ours may
indicate that angiogenesis is copper-dependent in the CNS
but not elsewhere.
Differences in the duration of copper deficiency prior to
tumour implantation between the present study and previous
work (1 vs 6 weeks) may be another possible explanation for
the difference in reported results. Farquharson et al. (1989)
proposed that tissue-specific cuproenzymes exist with differ-
ent copper requirements for activity. There is also evidence
for organ-specific uptake of copper (Pickart, 1983). This
suggests that there is varying susceptibility of copper-depen-
dent enzymes to copper deficiency. However, copper
deficiency of the duration and level achieved in the present
study has been previously shown to cause both biochemical
and physiological alterations.
Endothelium-dependent and -independent vasoactive res-
ponses are significantly reduced after periods ranging from 17
to 27 days on the same copper deficient diet (Schuschke et
al., 1992). In addition, the same diet, within 1 week, pro-
duced a significant depression of plasma copper and liver
copper concentration and reduced Cu,Zn-superoxide dis-
mutase activity and within 14 days cytochrome c oxidase
activity was depressed, iron status was reduced and there was
significant anaemia. Within 21 days on the copper deficient
diet there was significant cardiac hypertrophy (Johnson &
Saari, 1991). Thus, while 7-21 days of this copper deficient
diet has produced considerable alterations of normal tissues,
there were no discernible effects on the tumour microcircula-
tion in this study.
Based on results from the current study and other pub-
lished reports, it appears that copper has a differential role in
neovascularisation and tumour growth. The data suggest that
the involvement of copper is either tumour-specific or host
tissue-specific and it is likely that the interaction of the two
tissues determine the final angiogenic and growth characteris-
tics.
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